TPG Capital

The Boston Globe Features Target ALS Founder, Dan Doctoroff

Announcing the Recipients of the 2024 In Vivo Target Validation Grants in Collaboration with Biospective

Advancing ALS Research: Key Insights and Breakthroughs from the 2024 International Symposium on ALS/MND

Join Us

Keep up with the latest news, events and ways to get involved.

Footer

Donate
Contact
Financial Reports
Call For Proposals
Annual Meeting
Privacy Policy
Credits

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140

Steck Insights WordPress Consulting

Join us this ALS Awareness Month to discover the people, stories, and science accelerating progress in ALS research.

Name(Required)

First Last

Email(Required)

Interests(Required)

Academic Researcher

Industry

Person with ALS

Caregiver

Loved one of person with ALS

Interested in the fight against ALS

Government

Updates on AGRI (ALS Global Research Initiative)

Mark the options that best describe your interest in ALS

Read more Interesting and Inspiring Articles

Join Us

Footer

Follow Us